After a brief perusal of earnings, this seems like a solid report. If the cancer detection business is actually starting to bottom, and Xoft can maintain it's growth for any period of time, ICAD will actually be profitable this year.
Also, congratulations to Deerfield Mgmt. on the revenue purchase agreement. That was clearly a wise move.
Must have been really brief. Dumped the rest of my shares today. Glad I doubled down. Things would have been different if they didn't do the reverse split. I would have let several thousand shares ride. With their debt and float it is much more serious a game. Fourth quarter EPS say what? I'll be back when I can make another long term bet.